Skip to main content

Peapod Lane Capital LLC

SEC CIK
0002050979
Latest filing
Jul 27, 2026

The latest 13F from Peapod Lane Capital LLC covers Q2 2026 (filed Jul 27, 2026): 61 long positions worth $148.2M. The top 10 holdings make up 32.2% of the portfolio, and the largest is Hurco Companies Inc (HURC) at 4.1%. Livermore has 7 filings on Form 13F from this institution, going back to Q4 2024.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
7
Est. +$10.5M
Added
42
Est. +$12.2M
Reduced
12
Est. −$9.39M
Sold out
8
Est. −$9.59M

Top 5 holdings

Share of this quarter's portfolio value

  1. HURCHurco Companies Inc
    4.1%$6.06MHistory
  2. CLDTChatham Lodging Trust
    4.1%$6.05MHistory
  3. ALCOAlico, Inc.
    3.3%$4.86MHistory
  4. ACTGAcacia Research Corp
    3.1%$4.64MHistory
  5. FLGTFulgent Genetics, Inc.
    3.1%$4.60MHistory

Share of portfolio

Top 5 holdings and the other 56 positions, by share of portfolio value

  1. HURC4.1%
  2. CLDT4.1%
  3. ALCO3.3%
  4. ACTG3.1%
  5. FLGT3.1%
  6. Other 56 positions82.3%

Biggest buys

New and added positions, by estimated amount bought

  1. BSETBassett Furniture Industries Inc
    +$2.19MNewHistory
  2. PCYOPure Cycle Corp
    +$2.00MNewHistory
  3. ENGNenGene Therapeutics Inc.
    +$1.91MNewHistory
  4. BCYCBicycle Therapeutics PLC
    +$1.77MAddedHistory
  5. MYPSPLAYSTUDIOS, Inc.
    +$1.50MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. ALOTAstroNova, Inc.
    +1.56 pp1.0% → 2.6%History
  2. BSETBassett Furniture Industries Inc
    +1.48 pp0.0% → 1.5%History
  3. PCYOPure Cycle Corp
    +1.35 pp0.0% → 1.3%History
  4. ENGNenGene Therapeutics Inc.
    +1.29 pp0.0% → 1.3%History
  5. MEIMethode Electronics Inc
    +1.21 pp0.6% → 1.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. CVGICommercial Vehicle Group, Inc.
    −$2.25MReducedHistory
  2. FDMT4D Molecular Therapeutics, Inc.
    −$2.21MSold outHistory
  3. FONRFonar Corp
    −$2.11MSold outHistory
  4. KVHIKVH Industries Inc
    −$1.63MReducedHistory
  5. TWINTwin Disc Inc
    −$1.62MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. FDMT4D Molecular Therapeutics, Inc.
    −1.81 pp1.8% → 0.0%History
  2. FONRFonar Corp
    −1.73 pp1.7% → 0.0%History
  3. KVHIKVH Industries Inc
    −1.36 pp3.0% → 1.7%History
  4. TWINTwin Disc Inc
    −1.33 pp1.3% → 0.0%History
  5. ALCOAlico, Inc.
    −1.23 pp4.5% → 3.3%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$148.2M
+$26.3M (+21.6%) vs. prior quarter
Positions
61
−1 vs. prior quarter
Top 10 concentration
32.2%
Top 10 as share of value
Turnover
14.1%
Q2 2026, one quarter
Average holding period
5.3 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2024), so positions held before then are understated.

13F filings by quarter

7 quarters, going back to Q4 2024. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $148.2M (Q2 2026)

Q4 2024: $100.9MQ1 2025: $88.9MQ2 2025: $99.9MQ3 2025: $111.8MQ4 2025: $117.5MQ1 2026: $121.9MQ2 2026: $148.2M
Q4 2024Q2 2026
13F filings of Peapod Lane Capital LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 27, 202661$148.2MHURCCLDTALCOvs. Q1 2026SEC
Q1 2026May 4, 202662$121.9MALCOACTGKVHIvs. Q4 2025SEC
Q4 2025Jan 28, 202659$117.5MALCOiShares Russell 2000 ETFANROvs. Q3 2025SEC
Q3 2025Nov 10, 202557$111.8MALCOSENEABHvs. Q2 2025SEC
Q2 2025Jul 31, 202557$99.9MHURCFSPALCOvs. Q1 2025SEC
Q1 2025Apr 30, 202561$88.9MFSPALCOSENEAvs. Q4 2024SEC
Q4 2024Jan 29, 202557$100.9MFSPHURCSENEA–SEC